Doxazosin mesylate - Generic Drug Details

What are the generic sources for doxazosin mesylate and what is the scope of freedom to operate?

Doxazosin mesylate is the generic ingredient in three branded drugs marketed by Viatris, Accord Hlthcare, Actavis Elizabeth, Ani Pharms, Apotex, Aurobindo Pharma Usa, Chartwell Rx, Genpharm, Heritage Pharma, Ivax Sub Teva Pharms, Nesher Pharms, Pharmgen, Pliva, Strides Pharma, Teva, Upsher Smith Labs, Watson Labs Inc, and Zydus Pharms, and is included in twenty NDAs. Additional information is available in the individual branded drug profile pages.

There are fourteen drug master file entries for doxazosin mesylate. Twenty-five suppliers are listed for this compound.

Summary for doxazosin mesylate

US Patents:	0
Tradenames:	3
Applicants:	18
NDAs:	20
Drug Master File Entries:	14
Finished Product Suppliers / Packagers:	25
Raw Ingredient (Bulk) Api Vendors:	103
Clinical Trials:	2
Patent Applications:	2,914
Formulation / Manufacturing:	see details
Drug Prices:	Drug price trends for doxazosin mesylate
Drug Sales Revenues:	Drug sales revenues for doxazosin mesylate
What excipients (inactive ingredients) are in doxazosin mesylate?	doxazosin mesylate excipients list
DailyMed Link:	doxazosin mesylate at DailyMed

See drug prices for doxazosin mesylate

See drug sales revenues for doxazosin mesylate

Recent Clinical Trials for doxazosin mesylate

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Pfizer
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
University of Minnesota	Phase 2

See all doxazosin mesylate clinical trials

Pharmacology for doxazosin mesylate

Drug Class	alpha-Adrenergic Blocker
Mechanism of Action	Adrenergic alpha-Antagonists

Medical Subject Heading (MeSH) Categories for doxazosin mesylate

Adrenergic alpha-1 Receptor Antagonists

Antihypertensive Agents

US Patents and Regulatory Information for doxazosin mesylate

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Teva	DOXAZOSIN MESYLATE	doxazosin mesylate	TABLET;ORAL	075536-002	Oct 18, 2000	AB	RX	No	No
Teva	DOXAZOSIN MESYLATE	doxazosin mesylate	TABLET;ORAL	075353-004	Jan 12, 2001		DISCN	No	No
Chartwell Rx	DOXAZOSIN MESYLATE	doxazosin mesylate	TABLET;ORAL	075646-001	Oct 18, 2000		DISCN	No	No
Accord Hlthcare	DOXAZOSIN MESYLATE	doxazosin mesylate	TABLET;ORAL	202824-001	Jun 11, 2014	AB	RX	No	No
Zydus Pharms	DOXAZOSIN MESYLATE	doxazosin mesylate	TABLET;ORAL	208719-004	Jul 7, 2017	AB	RX	No	No

Expired US Patents for doxazosin mesylate

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Viatris	CARDURA XL	doxazosin mesylate	TABLET, EXTENDED RELEASE;ORAL	021269-002	Feb 22, 2005
Viatris	CARDURA	doxazosin mesylate	TABLET;ORAL	019668-003	Nov 2, 1990
Viatris	CARDURA	doxazosin mesylate	TABLET;ORAL	019668-004	Nov 2, 1990
Viatris	CARDURA	doxazosin mesylate	TABLET;ORAL	019668-002	Nov 2, 1990
Viatris	CARDURA	doxazosin mesylate	TABLET;ORAL	019668-001	Nov 2, 1990